Maria Fardis

2016

In 2016, Maria Fardis earned a total compensation of $6.7M as President and Chief Executive Officer at Lion Biotechnologies.

Compensation breakdown

Non-Equity Incentive Plan$116,720
Option Awards$2,935,000
Salary$291,667
Stock Awards$3,228,500
Other$150,000
Total$6,721,887

Fardis received $3.2M in stock awards, accounting for 48% of the total pay in 2016.

Fardis also received $116.7K in non-equity incentive plan, $2.9M in option awards, $291.7K in salary and $150K in other compensation.

Rankings

In 2016, Maria Fardis' compensation ranked 998th out of 14,075 executives tracked by ExecPay. In other words, Fardis earned more than 92.9% of executives.

ClassificationRankingPercentile
All
998
out of 14,075
93rd
Division
Manufacturing
331
out of 5,489
94th
Major group
Chemicals And Allied Products
85
out of 1,895
96th
Industry group
Drugs
56
out of 1,538
96th
Industry
Biological Products, Except Diagnostic Substances
9
out of 279
97th
Source: SEC filing on April 29, 2019.

Fardis' colleagues

We found one more compensation record of an executive who worked with Maria Fardis at Lion Biotechnologies in 2016.

2016

Frederick Vogt

Lion Biotechnologies

General Counsel

News

You may also like